» Articles » PMID: 26968265

Alternative Splicing and Nonsense-mediated MRNA Decay Enforce Neural Specific Gene Expression

Overview
Specialty Neurology
Date 2016 Mar 13
PMID 26968265
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative pre-mRNA splicing is a fundamental regulatory process for most mammalian multi-exon genes to increase proteome diversity. Nonsense-mediated mRNA decay (NMD) is a conserved mRNA surveillance mechanism to mitigate deleterious effects caused by gene mutations or transcriptional errors. Coupling alternative splicing and NMD (AS-NMD), in which alternative splicing switches between translational and NMD isoforms, results in fine-tuning overall gene expression to, in turn, expand the functional activities of these two post-transcriptional regulatory processes. AS-NMD is known for maintaining homeostatic expression of many RNA-binding proteins. We further show that AS-NMD is a conserved mechanism among mammals to induce developmental expression of the synaptic scaffold protein PSD-95. Comparing gene sequences between human Psd-95 and its ancestral orthologues indicates that AS-NMD regulation of mammalian Psd-95 is a product of selective pressure and that it enforces neural-specific expression of PSD-95 proteins in mammals. Invertebrate homolog of Psd-95 is not subjected to AS-NMD regulation and its protein product does not exhibit neural-specific expression. Given the prevalence of alternative splicing regulation in the mammalian nervous system, neural-specific expression of many other genes could be controlled by AS-NMD in a similar manner. We discuss the implication of these discoveries, as well as the challenges in generalizing the regulation and functional activity of AS-NMD.

Citing Articles

Direct and indirect effects of spliceosome disruption compromise gene regulation by Nonsense-Mediated mRNA Decay.

Embree C, Stephanou A, Singh G bioRxiv. 2025; .

PMID: 39763844 PMC: 11703147. DOI: 10.1101/2024.12.27.630533.


Human introns contain conserved tissue-specific cryptic poison exons.

Margasyuk S, Kuznetsova A, Zavileyskiy L, Vlasenok M, Skvortsov D, Pervouchine D NAR Genom Bioinform. 2024; 6(4):lqae163.

PMID: 39664813 PMC: 11632617. DOI: 10.1093/nargab/lqae163.


Study of the RNA splicing kinetics via in vivo 5-EU labeling.

Bolikhova A, Buyan A, Mariasina S, Rudenko A, Chekh D, Mazur A RNA. 2024; 30(10):1356-1373.

PMID: 39048310 PMC: 11404452. DOI: 10.1261/rna.079937.123.


KIS counteracts PTBP2 and regulates alternative exon usage in neurons.

Moreno-Aguilera M, Neher A, Mendoza M, Dodel M, Mardakheh F, Ortiz R Elife. 2024; 13.

PMID: 38597390 PMC: 11045219. DOI: 10.7554/eLife.96048.


Perturbation of the insomnia WDR90 genome-wide association studies locus pinpoints rs3752495 as a causal variant influencing distal expression of neighboring gene, PIG-Q.

Sonti S, Littleton S, Pahl M, Zimmerman A, Chesi A, Palermo J Sleep. 2024; 47(7).

PMID: 38571402 PMC: 11236950. DOI: 10.1093/sleep/zsae085.


References
1.
Zheng S, Black D . Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends Genet. 2013; 29(8):442-8. PMC: 3959871. DOI: 10.1016/j.tig.2013.04.003. View

2.
Rebbapragada I, Lykke-Andersen J . Execution of nonsense-mediated mRNA decay: what defines a substrate?. Curr Opin Cell Biol. 2009; 21(3):394-402. DOI: 10.1016/j.ceb.2009.02.007. View

3.
Zibetti C, Adamo A, Binda C, Forneris F, Toffolo E, Verpelli C . Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system. J Neurosci. 2010; 30(7):2521-32. PMC: 6634524. DOI: 10.1523/JNEUROSCI.5500-09.2010. View

4.
Wang J, Telese F, Tan Y, Li W, Jin C, He X . LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control. Nat Neurosci. 2015; 18(9):1256-64. PMC: 4625987. DOI: 10.1038/nn.4069. View

5.
Lejeune F, Maquat L . Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol. 2005; 17(3):309-15. DOI: 10.1016/j.ceb.2005.03.002. View